HARRISBURG — Geisinger Clinic researchers received a state grant Wednesday to the tune of $110,249 to further their brain cancer treatment research.
The grant will allow research to move out of a laboratory and into a clinical setting, according to Geisinger Health System’s science and research directors Dr. David H. Ledbetter, Dr. Nikolaos Tapinos and and Dr. David Carey who accepted the grant on behalf of the hospital network.
Issued from Commonwealth Universal Research Enhancement (CURE) program funds, the grant is given for health research that intends to improve the state’s general health.
“We’re embarking on some exciting new territory in the treatment of brain cancer,” Carey said. “While difficult, this type of translational research is needed to drive continuous improvement in individual health.”
Grant eligibility requires recipients to pursue research that works toward statewide improved health and access to effective health care. Tapinos said their research targets what causes brain tumors to grow.
“Behind these promising developments is an increasing awareness that brain cancer isn’t one disease,” Tapinos said. “Each tumor has its own characteristics and our research is decoding the factor that allows some tumors to survive and grow.”
Since the grant program’s inception, Geisinger Clinic has received more than $5.3 million in CURE funding for various projects. Nearly $800 million has been granted statewide from CURE funds.